Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
作者信息
Drew Barbara J, Ackerman Michael J, Funk Marjorie, Gibler W Brian, Kligfield Paul, Menon Venu, Philippides George J, Roden Dan M, Zareba Wojciech
出版信息
J Am Coll Cardiol. 2010 Mar 2;55(9):934-47. doi: 10.1016/j.jacc.2010.01.001.
Abstract
摘要
相似文献
1
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
J Am Coll Cardiol. 2010 Mar 2;55(9):934-47. doi: 10.1016/j.jacc.2010.01.001.
2
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
Circulation. 2010 Mar 2;121(8):1047-60. doi: 10.1161/CIRCULATIONAHA.109.192704. Epub 2010 Feb 8.
3
Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
AACN Adv Crit Care. 2007 Jul-Sep;18(3):285-93. doi: 10.4037/15597768-2007-3007.
4
Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm.
Heart. 1998 Apr;79(4):417-9. doi: 10.1136/hrt.79.4.417.
5
Recognizing and treating torsade de pointes.
Crit Care Nurse. 1992 Jun;12(5):23-9.
6
Quasi-experimental study to improve nurses' QT-interval monitoring: results of QTIP study.
Am J Crit Care. 2012 May;21(3):195-200; quiz 201. doi: 10.4037/ajcc2012245.
7
Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
J Anesth. 2017 Jun;31(3):413-423. doi: 10.1007/s00540-017-2314-6. Epub 2017 Feb 22.
8
Nicorandil successfully abolished intraoperative torsade de pointes.
Anesthesiology. 1998 Jun;88(6):1669-71. doi: 10.1097/00000542-199806000-00033.
10
American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.
Heart Rhythm. 2008 Oct;5(10):e1-21. doi: 10.1016/j.hrthm.2008.05.031.
引用本文的文献
1
A Scary Tale of a Twisted Storm: A Case Report of Torsades De Pointes in Acquired Long QT Syndrome.
Cureus. 2025 Jun 23;17(6):e86577. doi: 10.7759/cureus.86577. eCollection 2025 Jun.
2
Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management.
Pharmaceuticals (Basel). 2025 May 26;18(6):800. doi: 10.3390/ph18060800.
3
Arrhythmia Inducibility in the CAVB Dog Model, A Critical Analysis on Underlying Factors.
Cardiovasc Toxicol. 2025 Sep;25(9):1344-1351. doi: 10.1007/s12012-025-10033-3. Epub 2025 Jun 24.
4
Psychotropic Polypharmacy and QT Prolonging Medications in Hospitalized Patients.
Pharmacol Res Perspect. 2025 Jun;13(3):e70107. doi: 10.1002/prp2.70107.
5
Risk Factors Associated with Unsuccessful Dofetilide Initiation Due to Excessive QT Interval Prolongation: A Retrospective Study.
J Innov Card Rhythm Manag. 2025 Apr 15;16(4):6240-6246. doi: 10.19102/icrm.2025.16042. eCollection 2025 Apr.
6
Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement of the European Heart Rhythm Association of the ESC.
Europace. 2025 Mar 30. doi: 10.1093/europace/euaf076.
7
Advanced QT interval analysis in long-term electrocardiography using shape-based clustering and template matching: A novel approach for Holter monitoring.
Heliyon. 2025 Feb 13;11(4):e42662. doi: 10.1016/j.heliyon.2025.e42662. eCollection 2025 Feb 28.
8
Surveillance of Corrected QT Interval-Prolonging Medications upon Admission throughout Hospitalization in a Tertiary Care Geriatric Ward.
Med Princ Pract. 2025;34(3):281-290. doi: 10.1159/000544820. Epub 2025 Feb 20.
9
A Polygenic Predictor of Baseline QTc is Associated With Sotalol-Induced QT Prolongation.
Circulation. 2024 Dec 10;150(24):1984-1986. doi: 10.1161/CIRCULATIONAHA.124.070337. Epub 2024 Dec 9.
10
Computerized QT and QTc Measurements From Bedside ICU Monitors Are Similar to Those Derived From a Standard 12-Lead ECG.
Ann Noninvasive Electrocardiol. 2025 Jan;30(1):e70031. doi: 10.1111/anec.70031.
本文引用的文献
1
QTc interval screening in methadone treatment.
Ann Intern Med. 2009 Mar 17;150(6):387-95. doi: 10.7326/0003-4819-150-6-200903170-00103. Epub 2009 Jan 19.
2
Atypical antipsychotic drugs and the risk of sudden cardiac death.
N Engl J Med. 2009 Jan 15;360(3):225-35. doi: 10.1056/NEJMoa0806994.
3
Drug induced QT prolongation.
Cardiol J. 2007;14(6):523-33.
4
Accurate electrocardiographic assessment of the QT interval: teach the tangent.
Heart Rhythm. 2008 Jul;5(7):1015-8. doi: 10.1016/j.hrthm.2008.03.037. Epub 2008 Apr 1.
5
Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest.
J Med Toxicol. 2008 Jun;4(2):101-5. doi: 10.1007/BF03160963.
6
Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome.
Heart Rhythm. 2008 May;5(5):712-5. doi: 10.1016/j.hrthm.2008.02.012. Epub 2008 Feb 16.
7
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):587-92. doi: 10.1002/pds.1607.
8
Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
J Electrocardiol. 2008 Mar-Apr;41(2):117-22. doi: 10.1016/j.jelectrocard.2007.09.009.
9
Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
J Am Coll Cardiol. 2008 Feb 26;51(8):836-42. doi: 10.1016/j.jacc.2007.09.066.
10
Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
AACN Adv Crit Care. 2007 Jul-Sep;18(3):285-93. doi: 10.4037/15597768-2007-3007.
Zotero 插件